alexa Newer Developments in the Nanoparticles for Cancer Trea
e-ISSN: 2347-7857 p-ISSN: 2347-7849

Research & Reviews: Journal of Pharmaceutics and Nanotechnology
Open Access

Like us on: https://twitter.com/PharmaNanotech
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Newer Developments in the Nanoparticles for Cancer Treatment.

 
To read the full article Peer-reviewed Article PDF image

Abstract

The surgery, radiation therapy and chemo therapy are the conventional treatments of cancers which have own limitations. Certain Nano Particles (NP) can be designed to absorb preferentially certain wave length of radiation if they enter in the cancerous cells then they will burn them. The NP will circulate through the body, detect cancer associated molecular changes, assist with imaging, release a therapeutic agent and then monitor the effectiveness of the intervention. Recent advancement in nanoparticles have been done with more emphasis on targeting of nanoparticle to the tumour cells which can decrease the side effects to the normal cells. They have been used in vivo to protect the drug entity in the systemic circulation, restrict access of the drug to the chosen sites and to deliver the drug at a controlled and sustained rate to the site of action. Over the last two decades, a large number of nanoparticle delivery systems have been developed for cancer therapy some of them are liposomal, polymer–drug conjugates, and micellar formulations and an even greater number of nanoparticle platforms are currently in the preclinical stages of development. In this review, we discuss the various nanoparticle drug delivery platforms, the important concepts involved in nanoparticle drug delivery and basis fundamentals behind targeting of nanoparticles. We have also reviewed the clinical data on the approved nanoparticle therapeutics as well as the nanotherapeutics under clinical investigation.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords